Inari Medical Inc (NARI)

Cash ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Cash and cash equivalents	US$ in thousands	38,597	89,182	57,837	56,562	60,222	83,528	79,724	186,556	92,752	81,158	91,322	102,903	114,229	167,988	194,836
Short-term investments	US$ in thousands	76,855	262,113	279,696	271,884	266,179	235,705	250,772	152,156	83,348	81,436	84,744	71,246	49,981	—	—
Total current liabilities	US$ in thousands	76,339	66,066	58,238	48,340	56,174	42,343	40,984	35,580	42,513	29,510	31,582	20,615	13,838	14,327	10,902
Cash ratio		1.51	5.32	5.80	6.79	5.81	7.54	8.06	9.52	4.14	5.51	5.57	8.45	11.87	11.73	17.87

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($38,597K + $76,855K) ÷ $76,339K
= 1.51

The cash ratio measures a company's ability to cover its short-term liabilities with its cash and cash equivalents. A higher cash ratio indicates a company has more liquidity to meet its obligations.

Inari Medical Inc's cash ratio has fluctuated over the past eight quarters, ranging from 1.60 to 9.68. The company's lowest cash ratio was 1.60 in Q4 2023, indicating a relatively lower ability to cover short-term liabilities with cash alone. However, in Q1 2022, the company had its highest cash ratio of 9.68, suggesting a strong liquidity position.

Overall, the trend shows some variability in Inari Medical Inc's ability to cover its short-term liabilities with cash. It would be important to delve deeper into the company's cash management practices and overall financial health to better understand the fluctuations in its cash ratio over time.